[Federal Register: February 18, 2004 (Volume 69, Number 32)] [Notices] [Page 7656] From the Federal Register Online via GPO Access [wais.access.gpo.gov] [DOCID:fr18fe04-65] ----------------------------------------------------------------------- DEPARTMENT OF JUSTICE Drug Enforcement Administration Manufacturer of Controlled Substances; Notice of Application Pursuant to Section 1301.33(a) of Title 21 of the Code of Federal Regulations (CFR), this is notice that on August 25, 2003, Johnson Matthey, Inc., Custom Pharmaceuticals Department, 2003 Nolte Drive, West Deptford, New Jersey 08066, made application by renewal to the Drug Enforcement Administration (DEA) for registration as a bulk manufacturer of the basic classes of controlled substances listed below: ------------------------------------------------------------------------ Drug Schedule ------------------------------------------------------------------------ Tetrahydrocannabinols (7370)................ I Difenoxin (9168)............................ I Propiram (9649)............................. I Amphetamine (1100).......................... II Methylphenidate (1724)...................... II Codeine (9050).............................. II Oxycodone (9143)............................ II Hydrocodone (9193).......................... II Meperidine (9230)........................... II Morphine (9300)............................. II Thebaine (9333)............................. II Alfentanil (9737)........................... II Sufentanil (9740)........................... II Fentanyl (9801)............................. II ------------------------------------------------------------------------ The firm plans to manufacture the listed controlled substances in bulk to supply to its customers. Any other such applicant and any person who is presently registered with DEA to manufacture such substance may file comments or objections to the issuance of the proposed registration. Any such comments or objections may be addressed, in quintuplicate, to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, United States Department of Justice, Washington, DC 20537, Attention: Federal Register Representative, Office of Chief Counsel (CCD) and must be filed no later than April 19, 2004. Dated: February 4, 2004. Laura M. Nagel, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 04-3476 Filed 2-17-04; 8:45 am] BILLING CODE 4410-09-M